Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.
about
Vaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in usePerformance of rotavirus vaccines in developed and developing countriesRotaviruses: from pathogenesis to vaccinationRotavirus vaccines and pathogenesis: 2008The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine TuberculosisEffectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysisThe clinical development process for a novel preventive vaccine: An overviewA systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacyRotavirus vaccines in routine useRotavirus vaccines: current status and future considerationsRemoving the age restrictions for rotavirus vaccination: a benefit-risk modeling analysisFindings from a comprehensive diarrhoea prevention and treatment programme in Lusaka, ZambiaRotavirus infection and disease in a multi-site birth cohort: Results from the MAL-ED study.Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic modelsCost-effectiveness of Rotavirus vaccination in VietnamHealth and economic impact of rotavirus vaccination in GAVI-eligible countriesThe effect of rotavirus vaccine on diarrhoea mortalityHospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania.Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size.Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis.Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study.A multi-center, qualitative assessment of pediatrician and maternal perspectives on rotavirus vaccines and the detection of Porcine circovirus.Retrospective surveillance for intussusception in children aged less than five years in a South Indian tertiary-care hospital.Global impact of rotavirus vaccines.Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.Protective effect of natural rotavirus infection in an Indian birth cohort.Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China.The human rotavirus vaccine Rotarix™ in infants: an integrated analysis of safety and reactogenicity.Understanding reduced rotavirus vaccine efficacy in low socio-economic settings.Genetic diversity of G3 rotavirus strains circulating in Argentina during 1998-2012 assessed by full genome analysesDemographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics.Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414.Disease caused by rotavirus infectionEpidemiology and genetic diversity of rotavirus strains in children with acute gastroenteritis in Lahore, Pakistan.Changing profile of rotavirus genotypes in Bangladesh, 2006-2012Rotarix: a rotavirus vaccine for the world.Human rotavirus group a serotypes causing gastroenteritis in children less than 5 years and HIV-infected adults in Viwandani slum, NairobiCost-effectiveness of rotavirus vaccination in Bolivia from the state perspective.
P2860
Q24197495-77F1C9B5-7CE6-4C91-877B-2EE4E7781918Q24203645-596FDE95-B4DF-4202-9EE4-C0650A0D3BE9Q24235411-07B46BE1-40BA-43E3-B16A-C0953766C201Q24600612-785F88AB-7C66-46D1-8F1A-95FA86CE37F2Q24609374-B2DD1949-BF06-473A-8216-EAF805DA6BCCQ24654275-C8315D17-0DC3-4D8A-BF97-CA52ED3C0319Q26740410-77138CFE-DF28-4A58-85F4-EA390C99FE03Q26741847-846A990D-85DD-4AB1-BBA7-AD7065DE7619Q26770871-F1CF8005-D098-4020-B85F-11DD409B148DQ26820819-36B77D0F-944E-4358-A2CC-8B0CFF72A5A1Q26853690-5010B9F4-437B-4612-8941-18843D9A5A6FQ27021385-6CE4FFCE-1D5A-4214-AD8D-78D0369831DBQ28484524-D5B63B44-D233-4A78-AA4E-009F95C2180CQ28601607-470C5250-EE1B-4B78-ACE6-DE8A148EB77FQ30252454-0EF361E6-757D-4BA6-B81E-1E90B07B6CB0Q31086859-C7A1A628-AC90-4BC7-A35B-0F6A5F6F8DB7Q33401714-8E118E43-5B93-4D21-9BB0-721D99180517Q33578406-C5C31457-DABE-44D8-8F75-1087F046231CQ33754470-BD246B3C-BBA4-436B-A6AB-6C8D63F4C0A9Q33794728-A3862441-4E67-4E70-84E2-3351EC5EF84AQ33875687-7C707D5C-D5B6-4393-8FE7-CF768D4B822FQ33883799-266BB566-824D-4CDC-B73A-0DA22CDD3C0BQ33915516-0BF1D7B5-5129-40CA-A287-61B5862632BEQ34029254-F5FA810F-4873-4F54-992C-1A359F954E81Q34083448-C5F78312-A6EF-43BC-8269-0D809A1799B0Q34108591-EC5FDF10-8E85-4DE5-97E3-5F45E2A65742Q34146235-FB8B32CD-4329-4D65-A377-2CFBFB97743EQ34203915-D48C8CF9-7E97-4902-ACCA-7609246FAB09Q34271468-94071383-B04B-496A-8BED-DC609356A9A0Q34271506-20E382ED-2EFA-4379-9C74-FEBC9E2DF241Q34374045-3AE7D237-60A4-46F1-AE2D-BC6CA6AC9648Q34388120-549AF236-20A3-4F85-A5EB-026B8C29212EQ34441419-00B87A76-CBD0-4DAE-B8B3-5490206BAD99Q34669133-8AF19896-771E-4297-991F-0D5307E4A22AQ34785330-FF697028-A35A-4464-ACAF-24DE4299E782Q34795202-3074C06C-DDA0-4BC5-ABF1-2D5D82633D35Q34820154-AEF2360C-5975-4106-B845-A694F2924331Q34900447-0B4E4ABD-6499-4EE1-8381-46E73B6C50AEQ35109584-E9789F9C-151E-42B5-B878-34C8CAAD5809Q35166897-F42D4AFF-93CA-41AA-99D6-8474A7F5FA37
P2860
Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Efficacy and safety of an oral ...... bo-controlled phase III study.
@en
Efficacy and safety of an oral ...... bo-controlled phase III study.
@nl
type
label
Efficacy and safety of an oral ...... bo-controlled phase III study.
@en
Efficacy and safety of an oral ...... bo-controlled phase III study.
@nl
prefLabel
Efficacy and safety of an oral ...... bo-controlled phase III study.
@en
Efficacy and safety of an oral ...... bo-controlled phase III study.
@nl
P2093
P921
P1433
P1476
Efficacy and safety of an oral ...... bo-controlled phase III study.
@en
P2093
Alain Bouckenooghe
Alexandre C Linhares
Béatrice De Vos
Doris Maribel Rivera-Medina
Eduardo Ortega-Barría
Ernesto Nuñez
F Raúl Velázquez
Felix Espinoza
Guillermo M Ruiz-Palacios
Hector Abate
P304
P356
10.1016/S0140-6736(08)60524-3
P407
P577
2008-04-01T00:00:00Z